The immune response of hamsters to purified haemagglutinins and whole influenza virus vaccines following live influenza virus infection
Identifieur interne : 000D08 ( Istex/Curation ); précédent : 000D07; suivant : 000D09The immune response of hamsters to purified haemagglutinins and whole influenza virus vaccines following live influenza virus infection
Auteurs : R. Jennings ; C. M. Brand [Royaume-Uni] ; C. Mclaren ; Lynda Shepherd ; C. W. PotterSource :
- Medical Microbiology and Immunology [ 0300-8584 ] ; 1974-11-01.
English descriptors
- Teeft :
- Antibody, Antibody response, Antibody titres, Detectable serum, Enhancement, Haemagglutinin, Haemagglutinin antigens, Haemagglutinins, Hamster, Heterotypic, Hong kong, Immune response, Immunization, Influenza, Influenza vaccines, Influenza virus, Influenza viruses, Split vaccine, Subsequent immunization, Titration vaccine, Vaccine, Vaccine virus, Virus, Whole virus vaccine.
Abstract
Abstract: The ability of several, live type A influenza viruses to enhance the serum haemagglutination-inhibiting (HI) antibody response of hamsters to subsequent immunization with inactivated, heterotypic influenza virus vaccines was examined. Live influenza viruses were found to vary in their priming ability for a given vaccine, and a given virus was not able to prime for all inactivated vaccines to an equal extent. Common determinants in the haemagglutinin antigens of the priming virus and the vaccine virus were suggested as responsible for the enhancement of the antibody response to some of the vaccines, but for other pairs of viruses the haemagglutinin antigens were distinct. Thus, enhancement in these instances cannot be due to cross-reacting haemagglutinins. Pre-infection of hamsters by several influenza type A viruses was employed in an attempt to enhance the serum HI antibody response to purified, haemagglutinin antigens prepared from A/PR/8/34 and the MRC-2 recombinant strain of A/England/42/72 viruses. Although prior infection enhanced the antibody response to whole virus, this was not demonstrable for the purified haemagglutinin components of the virus. The possible reasons for this are discussed.
Url:
DOI: 10.1007/BF02121445
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000D08
Links to Exploration step
ISTEX:D45FFF912A6B7603CA798E5501036031F37C3293Curation
No country items
R. Jennings<affiliation><mods:affiliation>Academic Division of Pathology, University of Sheffield, Sheffield</mods:affiliation><wicri:noCountry code="subField">Sheffield</wicri:noCountry></affiliation><affiliation><mods:affiliation>Academic Division of Pathology, University of Sheffield, Sheffield</mods:affiliation><wicri:noCountry code="subField">Sheffield</wicri:noCountry></affiliation><affiliation><mods:affiliation>Academic Division of Pathology, University of Sheffield, Sheffield</mods:affiliation><wicri:noCountry code="subField">Sheffield</wicri:noCountry></affiliation><affiliation><mods:affiliation>Academic Division of Pathology, University of Sheffield, Sheffield</mods:affiliation><wicri:noCountry code="subField">Sheffield</wicri:noCountry></affiliation>Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The immune response of hamsters to purified haemagglutinins and whole influenza virus vaccines following live influenza virus infection</title><author><name sortKey="Jennings, R" sort="Jennings, R" uniqKey="Jennings R" first="R." last="Jennings">R. Jennings</name><affiliation><mods:affiliation>Academic Division of Pathology, University of Sheffield, Sheffield</mods:affiliation><wicri:noCountry code="subField">Sheffield</wicri:noCountry></affiliation></author><author><name sortKey="Brand, C M" sort="Brand, C M" uniqKey="Brand C" first="C. M." last="Brand">C. M. Brand</name><affiliation><mods:affiliation>Academic Division of Pathology, University of Sheffield, Sheffield</mods:affiliation><wicri:noCountry code="subField">Sheffield</wicri:noCountry></affiliation><affiliation wicri:level="2"><mods:affiliation>Wellcome Research Laboratories, Langley Court, Beckenham, Kent, England</mods:affiliation><country>Royaume-Uni</country><placeName><region type="country">Angleterre</region></placeName><wicri:cityArea>Wellcome Research Laboratories, Langley Court, Beckenham, Kent</wicri:cityArea></affiliation></author><author><name sortKey="Mclaren, C" sort="Mclaren, C" uniqKey="Mclaren C" first="C." last="Mclaren">C. Mclaren</name><affiliation><mods:affiliation>Academic Division of Pathology, University of Sheffield, Sheffield</mods:affiliation><wicri:noCountry code="subField">Sheffield</wicri:noCountry></affiliation></author><author><name sortKey="Shepherd, Lynda" sort="Shepherd, Lynda" uniqKey="Shepherd L" first="Lynda" last="Shepherd">Lynda Shepherd</name><affiliation><mods:affiliation>Academic Division of Pathology, University of Sheffield, Sheffield</mods:affiliation><wicri:noCountry code="subField">Sheffield</wicri:noCountry></affiliation></author><author><name sortKey="Potter, C W" sort="Potter, C W" uniqKey="Potter C" first="C. W." last="Potter">C. W. Potter</name><affiliation><mods:affiliation>Academic Division of Pathology, University of Sheffield, Sheffield</mods:affiliation><wicri:noCountry code="subField">Sheffield</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D45FFF912A6B7603CA798E5501036031F37C3293</idno><date when="1974" year="1974">1974</date><idno type="doi">10.1007/BF02121445</idno><idno type="url">https://api.istex.fr/ark:/67375/1BB-W87HCM4C-R/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000D08</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000D08</idno><idno type="wicri:Area/Istex/Curation">000D08</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The immune response of hamsters to purified haemagglutinins and whole influenza virus vaccines following live influenza virus infection</title><author><name sortKey="Jennings, R" sort="Jennings, R" uniqKey="Jennings R" first="R." last="Jennings">R. Jennings</name><affiliation><mods:affiliation>Academic Division of Pathology, University of Sheffield, Sheffield</mods:affiliation><wicri:noCountry code="subField">Sheffield</wicri:noCountry></affiliation></author><author><name sortKey="Brand, C M" sort="Brand, C M" uniqKey="Brand C" first="C. M." last="Brand">C. M. Brand</name><affiliation><mods:affiliation>Academic Division of Pathology, University of Sheffield, Sheffield</mods:affiliation></affiliation><affiliation wicri:level="2"><mods:affiliation>Wellcome Research Laboratories, Langley Court, Beckenham, Kent, England</mods:affiliation><country>Royaume-Uni</country><placeName><region type="country">Angleterre</region></placeName><wicri:cityArea>Wellcome Research Laboratories, Langley Court, Beckenham, Kent</wicri:cityArea></affiliation></author><author><name sortKey="Mclaren, C" sort="Mclaren, C" uniqKey="Mclaren C" first="C." last="Mclaren">C. Mclaren</name><affiliation><mods:affiliation>Academic Division of Pathology, University of Sheffield, Sheffield</mods:affiliation><wicri:noCountry code="subField">Sheffield</wicri:noCountry></affiliation></author><author><name sortKey="Shepherd, Lynda" sort="Shepherd, Lynda" uniqKey="Shepherd L" first="Lynda" last="Shepherd">Lynda Shepherd</name><affiliation><mods:affiliation>Academic Division of Pathology, University of Sheffield, Sheffield</mods:affiliation><wicri:noCountry code="subField">Sheffield</wicri:noCountry></affiliation></author><author><name sortKey="Potter, C W" sort="Potter, C W" uniqKey="Potter C" first="C. W." last="Potter">C. W. Potter</name><affiliation><mods:affiliation>Academic Division of Pathology, University of Sheffield, Sheffield</mods:affiliation><wicri:noCountry code="subField">Sheffield</wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j">Medical Microbiology and Immunology</title><title level="j" type="abbrev">Med Microbiol Immunol</title><idno type="ISSN">0300-8584</idno><idno type="eISSN">1432-1831</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Berlin/Heidelberg</pubPlace><date type="published" when="1974-11-01">1974-11-01</date><biblScope unit="volume">160</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="295">295</biblScope><biblScope unit="page" to="309">309</biblScope></imprint><idno type="ISSN">0300-8584</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0300-8584</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Antibody</term><term>Antibody response</term><term>Antibody titres</term><term>Detectable serum</term><term>Enhancement</term><term>Haemagglutinin</term><term>Haemagglutinin antigens</term><term>Haemagglutinins</term><term>Hamster</term><term>Heterotypic</term><term>Hong kong</term><term>Immune response</term><term>Immunization</term><term>Influenza</term><term>Influenza vaccines</term><term>Influenza virus</term><term>Influenza viruses</term><term>Split vaccine</term><term>Subsequent immunization</term><term>Titration vaccine</term><term>Vaccine</term><term>Vaccine virus</term><term>Virus</term><term>Whole virus vaccine</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: The ability of several, live type A influenza viruses to enhance the serum haemagglutination-inhibiting (HI) antibody response of hamsters to subsequent immunization with inactivated, heterotypic influenza virus vaccines was examined. Live influenza viruses were found to vary in their priming ability for a given vaccine, and a given virus was not able to prime for all inactivated vaccines to an equal extent. Common determinants in the haemagglutinin antigens of the priming virus and the vaccine virus were suggested as responsible for the enhancement of the antibody response to some of the vaccines, but for other pairs of viruses the haemagglutinin antigens were distinct. Thus, enhancement in these instances cannot be due to cross-reacting haemagglutinins. Pre-infection of hamsters by several influenza type A viruses was employed in an attempt to enhance the serum HI antibody response to purified, haemagglutinin antigens prepared from A/PR/8/34 and the MRC-2 recombinant strain of A/England/42/72 viruses. Although prior infection enhanced the antibody response to whole virus, this was not demonstrable for the purified haemagglutinin components of the virus. The possible reasons for this are discussed.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D08 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000D08 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:D45FFF912A6B7603CA798E5501036031F37C3293
|texte= The immune response of hamsters to purified haemagglutinins and whole influenza virus vaccines following live influenza virus infection
}}
| This area was generated with Dilib version V0.6.33. |  |